Your browser doesn't support javascript.
loading
Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy-results from the ACOSOG Z1041 (Alliance) trial.
Lesurf, R; Griffith, O L; Griffith, M; Hundal, J; Trani, L; Watson, M A; Aft, R; Ellis, M J; Ota, D; Suman, V J; Meric-Bernstam, F; Leitch, A M; Boughey, J C; Unzeitig, G; Buzdar, A U; Hunt, K K; Mardis, E R.
Afiliação
  • Lesurf R; McDonnell Genome Institute at Washington University School of Medicine, St Louis, USA
  • Griffith OL; McDonnell Genome Institute at Washington University School of Medicine, St Louis, USA
  • Griffith M; Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, USA
  • Hundal J; Siteman Cancer Center, Washington University School of Medicine, St Louis, USA
  • Trani L; McDonnell Genome Institute at Washington University School of Medicine, St Louis, USA
  • Watson MA; Siteman Cancer Center, Washington University School of Medicine, St Louis, USA
  • Aft R; Department of Genetics, Washington University School of Medicine, St Louis, USA
  • Ellis MJ; McDonnell Genome Institute at Washington University School of Medicine, St Louis, USA
  • Ota D; McDonnell Genome Institute at Washington University School of Medicine, St Louis, USA
  • Suman VJ; Department of Pathology & Immunology, Washington University School of Medicine, St. Louis.
  • Meric-Bernstam F; Siteman Cancer Center, Washington University School of Medicine, St Louis, USA
  • Leitch AM; McDonnell Genome Institute at Washington University School of Medicine, St Louis, USA
  • Boughey JC; Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, USA
  • Unzeitig G; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, USA
  • Buzdar AU; Duke University Medical Center, Durham.
  • Hunt KK; Alliance Statistics and Data Center, Mayo Clinic, Rochester.
  • Mardis ER; The University of Texas MD Anderson Cancer Center, Houston.
Ann Oncol ; 28(5): 1070-1077, 2017 05 01.
Article em En | MEDLINE | ID: mdl-28453704
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Trastuzumab / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Trastuzumab / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos